Astera Labs, Inc. $ALAB Holdings Raised by Nomura Asset Management Co. Ltd.
Nomura Asset Management Co. Ltd. increased its stake in Astera Labs, Inc. by 50.2% in Q2, owning 596,130 shares valued at $53.9 million. Institutional investors hold 60.47% of Astera Labs' stock. Analysts have mixed ratings, with a consensus of 'Moderate Buy' and an average price target of $184.82. Recent insider transactions include significant stock sales by Director Jack R. Lazar and General Counsel Philip Mazzara. Astera Labs' stock opened at $141.39, with a market cap of $23.88 billion.
Nomura Asset Management Co. Ltd. boosted its stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 50.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 596,130 shares of the company's stock after buying an additional 199,330 shares during the period. Nomura Asset Management Co. Ltd. owned 0.36% of Astera Labs worth $53,902,000 at the end of the most recent quarter.
- Follow the Money: 3 Stocks With High Institutional Ownership
Several other large investors have also recently bought and sold shares of the stock. Oliver Lagore Vanvalin Investment Group acquired a new stake in shares of Astera Labs in the 2nd quarter worth approximately $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs during the second quarter worth approximately $36,000. Clearstead Trust LLC lifted its position in Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company's stock worth $42,000 after purchasing an additional 461 shares during the period. Harbour Investments Inc. boosted its stake in Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after purchasing an additional 619 shares in the last quarter. Finally, Hazlett Burt & Watson Inc. boosted its stake in Astera Labs by 1,670.0% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock valued at $53,000 after purchasing an additional 835 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently commented on ALAB shares. TD Cowen dropped their price objective on Astera Labs from $225.00 to $170.00 and set a "hold" rating on the stock in a research note on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their target price on Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a report on Tuesday, September 2nd. Evercore ISI upped their price target on shares of Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a report on Wednesday, August 6th. Needham & Company LLC raised their price objective on shares of Astera Labs from $205.00 to $220.00 and gave the company a "buy" rating in a research report on Wednesday, November 5th. Finally, Northland Securities set a $175.00 price objective on shares of Astera Labs in a research note on Monday. Fourteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $184.82.
- Are These 3 Beaten-Down Stocks Ready to Rebound?
View Our Latest Stock Analysis on ALAB
Insider Transactions at Astera Labs
In related news, Director Jack R. Lazar sold 22,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total value of $4,014,450.00. Following the completion of the transaction, the director owned 97,351 shares of the company's stock, valued at approximately $17,369,365.42. This trade represents a 18.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the transaction, the general counsel owned 151,573 shares in the company, valued at approximately $29,126,267.68. The trade was a 6.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 225,500 shares of company stock valued at $39,531,460 over the last ninety days. Corporate insiders own 12.50% of the company's stock.
Astera Labs Stock Down 2.0%
- 4 Stocks Every AI ETF Is Buying—And They’re Not What You Think
Shares of NASDAQ ALAB opened at $141.39 on Tuesday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The company has a market cap of $23.88 billion, a price-to-earnings ratio of 127.38, a P/E/G ratio of 2.69 and a beta of 1.38. The business has a fifty day simple moving average of $192.00 and a 200-day simple moving average of $144.85.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.10. The firm had revenue of $230.58 million for the quarter, compared to analysts' expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.Astera Labs's revenue was up 103.9% on a year-over-year basis. During the same quarter last year, the business posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.
About Astera Labs
(Free Report)Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- Profitably Trade Stocks at 52-Week Highs
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- Stock Market Sectors: What Are They and How Many Are There?
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Astera Labs Right Now?
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
